# Medcura

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/medcura

- Industry: Medical Devices & Equipment
- Headquarters: US
- Website: www.medcurainc.com
- Latest round: Seed (Jul 1, 2020)
- Investors on record: 3

## About

Founded in 2013 and based in Maryland, US, Medcura Inc. is a medical device company that develops hemostatic and wound treatment products. In March 2024, Medcura Inc. raised USD 22.4 million in venture debt funding. The firm as of August 2024, is led by its President, CEO, and Director, Jim Buck.

Medcura specializes in advanced hemostatic solutions using biopolymer technologies to manage surgical bleeding. Its flagship product, LifeGel™, controls bleeding effectively without the swelling issues common in existing agents. Utilizing hydrophobically modified chitosan, Medcura's technology creates a mechanical barrier through mucoadhesion, improving bleeding management and reducing costs across various procedures, including spine, cardiac, and minimally invasive surgeries. The company’s portfolio features a range of products, including bandages, foams, putties, surgical gels, and powders.

The company plans to utilize the March 2024 funding to accelerate the development of its lead surgical product, LifeGel™ Absorbable Hemostatic Gel.

## Funding rounds

- Seed, Jul 1, 2020 — Sky Ventures Group
- Seed, Nov 1, 2016 — Robin Hood Ventures, New York Angels

## Investors

- Robin Hood Ventures (https://capitalatlas.ai/funds/robin-hood-ventures) — Seed
- New York Angels (https://capitalatlas.ai/funds/new-york-angels) — Seed
- Sky Ventures Group (https://capitalatlas.ai/funds/sky-ventures-group) — Seed